Madsen Cecilie Maria, Boyd Ben, Rades Thomas, Müllertz Anette
Department of Pharmacy, Faculty of Health and Medical sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.
Drug Delivery, Disposition and Dynamics and ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, VIC, Australia.
Eur J Pharm Sci. 2016 Aug 25;91:31-9. doi: 10.1016/j.ejps.2016.05.026. Epub 2016 May 31.
Poor water solubility is a bottle neck in the development of many new drug candidates, and understanding and circumventing this is essential for a more effective drug development. Zafirlukast (ZA) is a leukotriene antagonist marketed for the treatment of asthma (Accolate®). ZA is poorly water soluble, and is formulated in an amorphous form (aZA) to improve its solubility and oral bioavailability. It has been shown that upon dissolution of aZa, the concentration of ZA in solution is supersaturated with respect to its stable crystalline form (ZA monohydrate), and thus, in theory, the bioavailability increases upon amorphization of ZA. The polymers hydroxypropylmethylcellulose (HPMC) and polyvinylpyrrolidone (PVP), often used as stabilizers of the supersaturated state, are in the excipient list of Accolate®. It is not recommended to take Accolate® with food, as this reduces the bioavailability by 40%. The aim of this study was to investigate the effect of simulated fasted and fed state intestinal media as well as the effect of HPMC and PVP on the supersaturation and precipitation of ZA in vitro. Supersaturation of aZA was studied in vitro in a small scale setup using the μDiss Profiler™. Several media were used for this study: One medium simulating the fasted state intestinal fluids and three media simulating different fed state intestinal fluids. Solid state changes of the drug were investigated by small angle x-ray scattering. The duration wherein aZA was maintained at a supersaturated state was prolonged in the presence of HPMC and lasted more than 20h in the presence of PVP in a fasted state intestinal medium. The presence of PVP increased the concentration of drug dissolved in the supersaturated state. The duration of supersaturation was shorter in fed than in a fasted state simulated intestinal media, but the concentration during supersaturation was higher. It was thus not possible to predict any positive or negative food effects from the dissolution/precipitation curves from different media. Lipolysis products in the fed state simulated media seemed to cause both a negative effect on the duration of supersaturation, and an increased drug concentration during supersaturation. In contrast, when testing the effect of a fed state simulated medium compared to the fasted state medium, in the presence of PVP, a clear negative effect was seen on the dissolution/precipitation curved of the fed state medium. The drug concentration during supersaturation was marginally different in the two media, but a precipitation of ZA was seen in the fed state medium, which was not observed in the fasted state medium. Solid state transformation from aZA to ZA monohydrate (mhZA) upon precipitation of the supersaturated solutions was confirmed by small angle x-ray scattering. All of these results can explain the described in vivo behavior of ZA. For ZA simple dissolution experiments in vitro can be used to examine supersaturation, effectiveness of PI and potential food effects on these.
水溶性差是许多新药研发过程中的一个瓶颈,了解并克服这一问题对于更有效的药物研发至关重要。扎鲁司特(ZA)是一种用于治疗哮喘的白三烯拮抗剂(Accolate®)。ZA的水溶性较差,以无定形形式(aZA)进行制剂,以提高其溶解度和口服生物利用度。研究表明,aZA溶解后,溶液中ZA的浓度相对于其稳定的结晶形式(ZA一水合物)是过饱和的,因此,理论上,ZA无定形化后生物利用度会提高。聚合物羟丙基甲基纤维素(HPMC)和聚乙烯吡咯烷酮(PVP)常被用作过饱和状态的稳定剂,在Accolate®的辅料清单中。不建议在进食时服用Accolate®,因为这会使生物利用度降低40%。本研究的目的是研究模拟禁食和进食状态的肠道介质以及HPMC和PVP对ZA体外过饱和和沉淀的影响。使用μDiss Profiler™在小规模装置中体外研究aZA的过饱和情况。本研究使用了几种介质:一种模拟禁食状态的肠道液,三种模拟不同进食状态的肠道液。通过小角X射线散射研究药物的固态变化。在禁食状态的肠道介质中,HPMC存在时aZA维持过饱和状态的持续时间延长,PVP存在时持续时间超过20小时。PVP的存在增加了过饱和状态下溶解的药物浓度。进食状态模拟肠道介质中的过饱和持续时间比禁食状态短,但过饱和期间的浓度更高。因此,无法从不同介质的溶解/沉淀曲线预测任何正面或负面的食物影响。进食状态模拟介质中的脂解产物似乎对过饱和持续时间有负面影响,并且在过饱和期间药物浓度增加。相反,在PVP存在的情况下,测试进食状态模拟介质与禁食状态介质相比的影响时,进食状态介质的溶解/沉淀曲线出现明显的负面影响。两种介质中过饱和期间的药物浓度略有不同,但在进食状态介质中观察到ZA沉淀,而在禁食状态介质中未观察到。通过小角X射线散射证实了过饱和溶液沉淀后从aZA到ZA一水合物(mhZA)的固态转变。所有这些结果都可以解释ZA在体内的行为。对于ZA,体外简单的溶解实验可用于检查过饱和、PI的有效性以及食物对这些的潜在影响。